Pseudopseudohypoparathyroidism

MONDO:0012912

A disease characterized by a constellation of clinical features collectively termed Albright hereditary osteodystrophy (AHO) but no evidence of resistance to parathyroid hormone (PTH), which is seen in other forms of pseudohypoparathyroidism (PHP).

Also known as: Albright Hereditary osteodystrophy with multiple hormone resistance, Albright hereditary osteodystrophy-PPHP syndrome, Normocalcemic pseudohypoparathyroidism (disorder) [ambiguous], aho-PPHP syndrome, pseudopseudohypoparathyroidism, Albright hereditary osteodystrophy without multiple hormone resistance, PPHP, Pseudopseudo-hypoparathyroidism

5 clinical trials for this condition and its sub-types, 2 tagged with Pseudopseudohypoparathyroidism itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Pseudohypoparathyroidism (9) ↑ Acromelic dysplasia (8) ↑ Disorder of GNAS inactivation (7)

Including sub-types (5) Tagged with Pseudopseudohypoparathyroidism (2)

Trials to join now! 1 Not yet finished but already full! 3 Terminated 1

Could a diabetes drug protect kidneys in children with genetic disease?

Disease control Recruiting now

This study tests whether adding dapagliflozin (a diabetes drug) to standard care reduces protein leakage in the urine of children with hereditary kidney diseases. About 44 children will receive either dapagliflozin plus standard care or standard care alone for 12 weeks, then swit…

Phase 3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Pseudopseudohypoparathyroidism

Where it sits in the disease tree

Could a diabetes drug protect kidneys in children with genetic disease?